ZYBERNO
Stock Report
Updated Aug 31, 2026

AdaptHealth Corp. (AHCO)

Healthcare • NASDAQ

$5.79

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
26.0/100
POOR BUSINESS
AdaptHealth Corp. (AHCO) scores 26/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
MARGIN OF SAFETY
Is this stock cheap or expensive relative to what the business has historically generated for owners?
+88.1%
Undervalued
Growth gap unavailable — insufficient data for reverse DCF calculation.
🎯 Expected Annual Return
83.7%
Margin of Safety convergence — your return if the market re-prices to intrinsic value (5-yr annualised)
25.0%
Yield + growth — what the business alone earns you, even if the market never re-rates
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-15.1%)
Debt-to-Equity (Solvency Risk):POOR (1.49x)
Operating Margin (Operational Efficiency):CRITICAL (-1.3%)
Return on Capital (Capital Efficiency):CRITICAL (-0.8%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

AdaptHealth Corp. (AHCO) stock report — Zyberno Score 26/100 (POOR BUSINESS), Margin of Safety +88.1%, 84% expected annual return. Full financial analysis on Zyberno.

According to Zyberno's DCF model, AdaptHealth Corp. (AHCO) trades at $5.79 against an estimated intrinsic value per share of $48.71 — a +88.1% Margin of Safety based on Owner Earnings of $213.08M TTM, projected at 34.3% growth for 10 years with a 2.5% terminal growth rate. Zyberno's model translates this into a 5-year expected return of 83.7% annually.

Over the trailing twelve months, AHCO generated $213.08M in Owner Earnings. Capital was deployed as follows: $408.02M invested in capital expenditures. Reinvestment rate: 249.6%. Owner Earnings have grown at 34.3% annually over the trailing five years using log-linear regression.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:5.79
Market Cap:$788.13M

Valuation Multiples (3)

P/B Ratio:0.57x
P/S Ratio:0.24x
Peg Ratio:-999.00x

Enterprise Metrics (3)

Enterprise Value:$3.24B
Ev Ebitda Ratio:8.31x
Pfcf Ratio:4.11x

Price Action & Momentum (3)

Momentum Percentile:54 / 100
% of 52-Week High:43.1%
B. Profitability Assessment

Return Metrics (5)

ROA:-5.2%
Reinvestment Rate:249.6%
Fundamental Growth Rate (g):-2.0%

Margin Analysis (3)

Operating Margin Ttm:-1.3%
Net Margin Ttm:-7.1%
Ebitda Margin:12.1%

TTM Performance (3)

Gross Margin Ttm:17.0%
Operating Margin Ttm:-1.3%
Net Margin Ttm:-7.1%

Yield Metrics (3)

Earnings Yield:-$29.02
Owner Earnings Yield:$27.04
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-8,900.0%
Latest Earnings Filed:2026-08-04

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):1.0%

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):3.2%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):70.4%
Operating Cash Flow Growth Rate (Linear):10.1%

Operating Growth (Linear) (1)

Operating Income Growth Rate (Linear):-12.8%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.12x
Quick Ratio:0.98x
Cash Ratio:0.00x

Leverage Analysis (3)

Debt To Equity Ttm:1.49x
Debt-to-Equity Ratio:1.49x
Debt To Ebitda:6.29x

Coverage Ratios (2)

Interest Coverage Ratio:2.89x
Times Interest Earned:2.89

Capital Structure (4)

Working Capital:88,263,000.00
Cash And Cash Equivalents:0.00
Long Term Debt:$1.88B
Net Debt:$2.46B
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $3.23B
Linear Growth: 1.0%
📊 Click to view full AHCO Revenue analysis & methodology →
Cost Of Revenue Ttm:$2.68B

Profitability Breakdown (2)

Gross profit TTM: $549.81M
Linear Growth: 10.7%
📊 Click to view full AHCO Gross Profit analysis & methodology →
Operating income TTM: -$41.44M
Linear Growth: -12.8%
📊 Click to view full AHCO Operating Income analysis & methodology →

Bottom Line Performance (3)

Net income TTM: -$228.23M
Linear Growth: 3.2%
📊 Click to view full AHCO Net Income analysis & methodology →
Income Before Tax:-$247.08M
Ebitda Ttm:390,460,000.00

Operating Expenses (5)

Operating Expenses:3,377,217,000.00
R And D Expense:0.00
Sga Expense:390,004,000.00
Income Tax Expense:-$12.32M
Interest Expense:31,429,000.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:52.7%
Ebitda Margin:12.1%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$4.34B
Current Assets:$797.48M
Ppe Net:656,368,000.00
Goodwill:2,370,431,000.00
Intangible Assets:$31.78M

Liability Structure (4)

Total Liabilities:2,954,613,000.00
Current Liabilities:709,212,000.00
Long Term Debt:$1.88B
Short Term Debt:$576.30M

Equity & Capital (3)

Equity:$1.39B
Retained Earnings:-$782.94M
Common Stock:300,000,000.00

Working Capital Items (3)

Accounts Receivable:390,389,000.00
Inventory:105,480,000.00
Accounts Payable:389,520,000.00

Special Items (2)

Contract Liabilities:64,743,000.00
Stock Based Compensation:5,400,000.00
C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: $599.97M
Linear Growth: 10.1%
Free cash flow TTM: $191.95M
Linear Growth: 70.4%
📊 Click to view full AHCO Free Cash Flow analysis & methodology →

Investment Activities (2)

Investing Cash Flow:-$204.46M
Capital Expenditures Ttm:408,015,000.00

Financing Activities (3)

Financing Cash Flow:$52.56M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$14.06M

Non-Cash Items (1)

Depreciation Amortization Ttm:431,900,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-1.68
Eps diluted TTM: -$1.68
Linear Growth: 32.9%
📊 Click to view full AHCO EPS analysis & methodology →
Earnings Per Share Ttm:-$1.68

Revenue & Cash Per Share (3)

Sales Per Share Ttm:23.70
Operating Cash Flow Per Share:$4.42
Fcf Per Share Ttm:1.41

Book Value & Capital (2)

Book Value Per Share:$10.18
Cash Per Share:-999.00

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.74x
Working Capital Turnover Ttm:36.56x

Receivables Management (2)

Receivables Turnover Ttm:8.27x
Days Sales Outstanding Ttm:44.16

Inventory Management (2)

Inventory Turnover Ttm:25.38x
Days Inventory Outstanding Ttm:14.38

Payables & Cash Cycle (2)

Days Payable Outstanding:53.11
Cash Conversion Cycle:5.43
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:35.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (3)

Owner earnings TTM: $213.08M
Linear Growth: 34.3%
📊 Click to view full AHCO Owner Earnings analysis & methodology →
Owner Earnings Per Share:$1.57
Owner Earnings Yield:$27.04

Growth Assessment (1)

Owner Earnings Growth Rate:$34.28

Damodaran Growth Analysis (2)

Reinvestment Rate:249.6%
Fundamental Growth Rate (g):-2.0%

Intrinsic Value Models (1)

Return Scenarios (2)

Investment Assessment (1)

Buffett Assessment:Excellent margin of safety
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (3)

Revenue Growth Rate (Linear):1.0%
Net Income Growth Rate (Linear):3.2%
Operating Income Growth Rate (Linear):-12.8%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):70.4%
Operating Cash Flow Growth Rate (Linear):10.1%

Other Growth Rates (3)

Gross Profit Growth Rate (Linear):10.7%
Book Value Growth Rate (Linear):-9.6%
Owner Earnings Growth Rate:$34.28
C. Company Profile & Context

Corporate Information (6)

Symbol:AHCO
Company Name:AdaptHealth Corp.
Sector:Healthcare
Industry:Services-Home Health Care Services
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:136.12M
Shares Outstanding Basic:136.12M
Shares Outstanding Diluted:136.12M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-31 19:15:18 UTC
Data Timestamp:2026-08-31T19:15:18.672243
Scroll to Top